In the present study patients randomized to placebo, and receiving usual care, showed a trend towards a decline of left ventricular performance while the opposite was observed in those patients receiving trimetazidine on top of usual care.
← all excerpts
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
1
—
—